← Leaderboards
Erika Augustine
University Of Rochester
$6,110,416
Attributed
$6,772,122
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,184,993 · 5
FDA$375,497 · 1
By mechanism
U01$3,731,631 · 1
U54$3,129,949 · 3
U24$1,323,413 · 1
R01$375,497 · 1
Top collaborators
- Ellen M. Mowry3 shared
Most similar at University Of Rochester
Same institution · by research overlap
- David A Pearce$11,215,112
- Heather Adams$639,425
- Kuan Hong Wang$5,861,974
- Jianhui Zhong$3,235,819
- Ruchira Singh$7,225,302
Others in their field
Top investigators on “Rare Diseases”
- Richard A Gibbs · Baylor College Of Medicine$172,164,288
- Peter C Adamson · National Childhood Cancer Foundation$156,659,650
- James D Crapo · University Of Colorado Denver$75,971,906
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Michael A Province · Washington University$68,490,372
- Jeffrey P Krischer · University Of South Florida$63,824,555
Research focus
Rare DiseasesClinical TrialsAffectChildhoodDesignCollaborationsProgramsEpilepsySiteNovel TherapeuticsChildEnsureFoundationsSamplingFutureSpielmeyer-Vogt DiseaseUniversitiesTraining ProgramsNeuronal Ceroid-LipofuscinosisComplexBlindnessMulticenter TrialsReadinessMotor Disorder
Grant awards (14)
Batten Disease Clinical Research Consortium$1,788,368
U54 · FY2025 · HD · contact PI
Research Project 1$984,021
U54 · FY2025 · HD · contact PI
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site$434,078
U24 · FY2025 · NS · contact PI
BDCRC - Administrative Core$357,560
U54 · FY2025 · HD · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$610,733
U01 · FY2024 · NS · contact PI
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site$427,108
U24 · FY2024 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$707,937
U01 · FY2023 · NS · contact PI
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site$462,227
U24 · FY2023 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$745,729
U01 · FY2021 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$747,799
U01 · FY2020 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$153,983
U01 · FY2020 · NS · contact PI
Meaningful Outcomes and Multi-Site Readiness for Clinical Trials in Juvenile Neuronal Ceroid Lipofuscinosis$765,450
U01 · FY2019 · NS · contact PI
Phase 2 of CellCept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis$176,049
R01 · FY2014 · FD · contact PI
Phase 2 of CellCept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis$199,448
R01 · FY2013 · FD · contact PI